Guangzhou Kingmed Diagnostics Group News

Jinyu Medical (603882): High base fluctuation routine has resumed

浙商證券Apr 29 00:00

Jinyu Medical (603882) 2023 Annual Report and 2024 Quarterly Report Review: Business Structure Optimization and Rapid Improvement of Testing Programs

西部證券Apr 28 19:31

Jinyu Medical (603882): Routine medical diagnostic services increased 15%, profitability is expected to recover

信達證券Apr 28 00:00

Jinyu Medical (603882): 2023 results are in line with expectations, regular business growth is steady

中金公司Apr 27 00:00

Jinyu Medical (603882): Related impairment dragged down current results

國泰君安Feb 19 19:11

Jinyu Medical (603882): The forecast is basically in line with expectations, and the impact of the COVID-19 base is gradually fading

中金公司Jan 31 12:36

Jinyu Medical (603882): Repurchase shares for equity incentive plans to help the company develop in the long term

華創證券Jan 25 18:21

Jinyu Medical (603882): The starting point for a new domestic ICL cycle

浙商證券Dec 28, 2023 00:00

Jinyu Medical (603882): The scale effect of leading ICL companies is gradually showing

國聯證券Dec 1, 2023 07:36

Jinyu Medical (603882): Adhering to innovation and long-term principles, ICL leaders begin a new chapter in development

國信證券Nov 29, 2023 18:06

Jinyu Medical (603882) 2023 Third Quarter Report Review: Performance is phased under pressure, and high-end business is progressing steadily

中信證券Nov 14, 2023 18:12

Jinyu Medical (603882): The proportion of customers in tertiary hospitals continues to rise, and credit impairment losses decline month-on-month

興業證券Nov 9, 2023 00:00

Jinyu Medical (603882): Steady growth in conventional business, deepening innovation and digital transformation

西南證券Nov 3, 2023 00:00

Jinyu Medical (603882) 2023 Third Quarter Report Review: Regular Business Revenue Steady Growth, Continued Advancement of Industry-University-Research Cooperation

華創證券Nov 2, 2023 13:42

Jinyu Medical (603882): Regular business growth is steady and innovation capabilities continue to increase

廣發證券Oct 30, 2023 00:00

Jinyu Medical (603882): 3Q23 performance was in line with expectations, credit impairment measures declined month-on-month

中金公司Oct 29, 2023 13:17

Jinyu Medical (603882): Key disease areas are growing rapidly and credit impairment losses are declining month-on-month

太平洋證券Oct 29, 2023 00:00

Jinyu Medical (603882): Short-term performance is under pressure, future prospects are still good

銀河證券Oct 29, 2023 00:00

Jinyu Medical (603882): Routine medical examinations are growing steadily, and digital transformation is progressing smoothly

國泰君安國際Oct 28, 2023 00:00

Jinyu Medical (603882): 23H1 performance is in line with expectations, regular business is steadily recovering

中信建投證券Oct 3, 2023 00:00